Effects of hydroxychloroquine sulfate combined with aspirin and enoxaparin sodium therapy on perinatal outcomes in patients with undifferentiated connective tissue disease-related recurrent miscarriage: a retrospective clinical study
Liu-Cheng Pei, Ting Wang, Ya-Juan Guo, Qiu-Ling Yang, Wen-Di Liu, Cheng-Wei Jiang, Peng-Chao Yan, Xue-Jie Li, Chun-Jun Wang · 2026
Read Effects of hydroxychloroquine sulfate combined with aspirin and enoxaparin sodium therapy on perinatal outcomes in patients with undifferentiated connective tissue disease-related recurrent miscarriage: a retrospective clinical study by Liu-Cheng Pei, Ting Wang, Ya-Juan Guo, Qiu-Ling Yang, Wen-Di Liu, Cheng-Wei Jiang, Peng-Chao Yan, Xue-Jie Li, Chun-Jun Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13393678.txt.
Description
Liu-Cheng Pei and coauthors test triple drug therapy for repeated miscarriage linked to undifferentiated connective tissue disease in a 2026 retrospective study. Women with this immune condition face repeated pregnancy loss, and the best drug combination for carrying a pregnancy to live birth was unsettled.
The study followed 135 pregnant women treated at one center between January 2021 and August 2024, comparing progesterone plus enoxaparin, aspirin plus enoxaparin, and a triple regimen adding hydroxychloroquine. Live birth at or after 28 weeks was the main outcome, with age and prior loss history adjusted. The paper guides treatment choices for a distressing and poorly studied condition.
Catalog record
| CREATOR | Liu-Cheng Pei, Ting Wang, Ya-Juan Guo, Qiu-Ling Yang, Wen-Di Liu, Cheng-Wei Jiang, Peng-Chao Yan, Xue-Jie Li, Chun-Jun Wang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |